Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. NRC

Market Cap: $475.98M

NH

NRC Health

NRC
NASDAQ (NASDAQ Global Select)USD
Purchase NRC
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin66.79%
EBITDA Margin16.73%
EBIT Margin10.56%
Pre-tax Margin6.70%
Net Profit Margin4.18%
Earnings Yield1.26%
Valuation Multiples
Price / Book70.98
Price / Sales3.40
Price / Earnings80.46
PEG-1.21
Forward PEG3.08
EV / Sales4.02
EV / EBITDA24.03
EV / Operating Cash Flow19.07
EV / Free Cash Flow26.00
Price / Free Cash Flow21.99
Price / Operating Cash Flow15.75
Cash Flow & Capital
Free Cash Flow / Share$0.98
Operating Cash Flow / Share$1.34
Free Cash Flow Yield4.55%
Capex / Revenue5.62%
Capex / Operating Cash Flow26.66%
Capex / Depreciation0.91
Stock Compensation / Revenue8.44%
Dividend Payout Ratio2.17%
Dividend Yield2.84%
Liquidity & Leverage
Current Ratio0.65
Quick Ratio0.65
Cash Ratio0.10
Debt / Assets0.66
Debt / Capital0.93
Debt / Equity13.75
Long-Term Debt / Capital0.93
Debt / Market Cap18.91%
Net Debt / EBITDA3.70
Solvency Ratio0.11
Financial Leverage20.79
Efficiency & Working Capital
Asset Turnover1.03
Fixed Asset Turnover3.54
Inventory Turnover0.00
Receivables Turnover10.26
Payables Turnover35.06
Days Sales Outstanding35.59
Days Inventory Outstanding0
Days Payables Outstanding10.41
Operating Cycle35.59
Cash Conversion Cycle25.18
Working Capital Turnover-9.12
Returns & Quality
Return on Equity48.46%
Return on Assets4.30%
Return on Invested Capital8.75%
ROCE14.57%
Return on Tangible Assets8.63%
Operating Return on Assets10.89%
Income Quality5.04
Tax Burden0.62
Interest Burden0.63
Balance Sheet & Intrinsic Metrics
Enterprise Value$562.68M
Invested Capital$95.54M
Working Capital$-12.21M
Tangible Asset Value$-61.71M
Net Current Asset Value$-106.8M
Graham Number$1.33
Graham Net-Net-$5.27
Book Value / Share$0.3
Tangible Book Value / Share-$2.8
Cash / Share$0.15
Financial Health Scores
Piotroski Score6
Altman Z-Score3.25
Revenue$140M
EBIT$14.79M
Market Cap$479.13M
Working Capital$-12.21M
Retained Earnings$-24.51M
Total Assets$136.15M
Total Liabilities$129.6M